Knowledge Center

Poster / Nov 12, 2017

Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment

Authors:
  • Maria Palha
  • Raquel Barros
  • Claudia Moura
  • Sofia Silva
  • Sara Cardoso
  • Eunice Costa
  • Marcio Temtem
Source:
AAPS 2017

In dry powders for inhalation the active pharmaceutical ingredient (API) is typically blended with excipients. However, poor drug delivery uniformity is frequently observed and the addition of a second API further increase the complexity of the formulation. In order to overcome these challenges, the engineering of carrier-free composite particles by spray drying (SD) is a suitable alternative.

Related links

Also in the Knowledge Center

Related Content

What we do

ËÄÉ«AV is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more

Devices

ËÄÉ«AV offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

Management

ËÄÉ«AV is an independent family owned international group of companies.

Page
Read more